Mesoblast (MESO) - 2023 Q2 - Earnings Call Presentation

Cash Reserves SR-aGVHD is associated with mortality rates as high as 90% mesoblast ASX: MSB; Nasdaq: MESO February 2023 This presentation includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by the ...